---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "tjJ8qivO7TRvKjv8kJnJCAjskwpAXS4TJrP20Ifz53Bx83a6Q0On5pp79zDnE6qAhjp2pQ2la4DSqIe6YqvUGH5TcIwgmS3PCwrK/d/F0tpHU80KPvc6yUptorDXRSo0ZlSGlHnZxN4an9+Gh8Z0S7YC6TFKgacpqm0797phwjt7pofKdpKEWumMJD75VX0Oq95BE3NmCWiu48BtQZRY1yUzJR043WaPirVT2i7+SwDba4yd7VQmFIjXlylJhv+xCoYlMqCjAQ53Va23wmIhwGp+/UnzJWTN5l0OonBe65rNfYiZdoTUoPNlkMiT5PHw;MJa48uW56AYDvuPHJt+bKQ=="
---

